The polymorphism of hypoxia-inducible factor-1a gene in endometrial cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 23, 2014, Pages 10393-10396

  Kafshdooz, Leila ^a,c   DastranjTabrizi, Ali ^a   Mohaddes, Seyyed Mojtaba ^b,c   Kafshdooz, Tayebeh ^a,c   Akbarzadeh, Abolfazl ^c   Ghojazadeh, Morteza ^a,b   Gharesouran, Jalal ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Endometrial carcinoma; HIF 1a polymorphism

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

CASE CONTROL STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MIDDLE AGED; NEOPLASM; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84921739787     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.23.10393     Document Type: Article

References (28)

1. Acmaz G, Aksoy H, Albayrak E, et al (2014). Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high risk group? Asian Pac J Cancer Prev, 15, 195-8.
2. Balik G, Kagitci M, Ustuner I, et al (2013). Which endometrial pathologies need intraoperative frozen sections? Asian Pac J Cancer Prev, 14, 6121-5.
3. Bansal N, Yendluri V, Wenham RM (2009). The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies, cancer control J Moffitt Cancer Center, 16, 8.
4. Cetinkaya K, Atalay F, Bacinoglu A (2014). Risk factors of lymph node metastases with endometrial carcinoma Asian Pac J Cancer Prev, 15, 6353.
5. Clifford SC, Astuti D, Hooper L, et al (2001). The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma, Oncogene, 20, 5067-74.
6. Epstein AC, Gleadle JM, McNeill LA, et al (2001). C elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell, 107, 43-54.
7. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE (2009). Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship, Gynecol Oncol, 114, 121-7.
8. Garcia-Dios DA, Lambrechts D, Coenegrachts L, et al (2013). High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma Gynecol Oncol, 128, 327-34.
9. Hebert C, Norris K, Parashar P, et al (2006). Hypoxia-inducible factor-1α polymorphisms and TSC1/2 mutations are complementary in head and neck cancers Molecular Cancer, 5, 3.
10. Hurwitz H, Fehrenbacher L, Novotny W, et al (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer New England J Med, 350, 2335-42.
11. Jiang XF, Tang QL, Zou Y, et al (2014). Does HBV infection increase risk of endometrial carcinoma? Asian Pac J Cancer Prev, 15, 713-6.
12. Kung AL, Klco JM, Kaelin WG, Livingston DM (2000). Suppression of tumor growth through disruption of hypoxia-inducible transcription, Nature Med, 6, 1335-40.
13. Ling TS, Shi RH, Zhang GX, et al (2005). Common single nucleotide polymorphism of hypoxia-inducible factor-1α and its impact on the clinicopathological features of esophageal squamous cell carcinoma Chinese J Digestive Diseases, 6, 155-8.
14. Liu FS (2007). Molecular carcinogenesis of endometrial cancer Taiwanese J Obstet Gynecol, 46, 26-32.
15. Mazurek A, Kuc P (2005). Angiogenesis-prognostic factor in patients with endometrial cancer Ginekologia Polska, 76, 838-45.
16. Minaguchi T, Yoshikawa H, Oda K, et al (2001). PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas Clinical Cancer Res, 7, 2636-42.
17. Myatt SS, Wang J, Monteiro LJ, et al (2010). Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer Cancer Res, 70, 367-77.
18. Neubauer NL, Lurain JR (2011). The role of lymphadenectomy in surgical staging of endometrial cancer. Internl J Surg Oncol, 2011, 814649.
19. Okuda T, Sekizawa A, Purwosunu Y, et al (2010). Genetics of endometrial cancers. Obstet Gynecol Internl.
20. Prat J, Gallardo A, Cuatrecasas M, Catasus L (2007). Endometrial carcinoma: pathology and genetics. Pathology, 39, 72-87.
21. Rasila K, Burger R, Smith H, Lee F, Verschraegen C (2005). Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Internl J Gynecol Cancer, 15, 710-26.
22. Sun H, Enomoto T, Fujita M, et al (2001). Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Am J Clin Pathol, 115, 32-8.
23. Tanimoto K, Yoshiga K, Eguchi H, et al (2003). Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis, 24, 1779-83.
24. Thanapprapasr D, Thanapprapasr K (2013). Molecular therapy as a future strategy in endometrial cancer. Asian Pac J Cancer Prev, 14, 3419-23.
25. Wang HL, Liu MM, Ma X, et al (2014). Expression and effects of JMJD2A histone demethylase in endometrial carcinoma.Asian Pac J Cancer Prev, 15, 3051.
26. Zeng YW, Yang JZ, Pu XY, et al (2013). Strategies of functional food for cancer prevention in human beings. Asian Pac J Cancer Prev, 14, 1585-92.
27. Zhao T, Lv J, Zhao J, Nzekebaloudou M (2009). Hypoxia-inducible factor-1α gene polymorphisms and cancer risk: a meta-analysis. J Experimental Clin Cancer Res, 28, 159.
28. Zhu XL, Ai ZH, Wang J, et al (2012). Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers. Asian Pac J Cancer Prev, 13, 4607-11.